REVIEW article

Front. Neurosci.

Sec. Neuroendocrine Science

Chronic Stress and Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: HPA Axis Dysregulation and Hippocampal Plasticity

  • 1. Changchun University of Chinese Medicine, Changchun, China

  • 2. The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China

  • 3. China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China

The final, formatted version of the article will be published soon.

Abstract

Cognitive dysfunction is a common and disabling clinical feature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), often described by patients as "brain fog." These symptoms typically manifest as difficulties in attention, memory, and concentration. Chronic stress has been proposed as an important contributing factor in ME/CFS. The hypothalamic-pituitary-adrenal (HPA) axis plays a central role in the stress response, and prolonged adverse stress may contribute to HPA axis dysregulation, including altered cortisol rhythmicity and impaired negative feedback regulation. Such dysregulation may be associated with cognitive dysfunction in ME/CFS through mechanisms involving neuroinflammatory responses, oxidative stress, and disturbances in neurotransmitter homeostasis. Studies suggest that these alterations may affect hippocampal structure and function, thereby contributing to impaired learning and memory processes. As a key brain region involved in cognition and stress regulation, the hippocampus may be implicated in the neurobiological mechanisms underlying cognitive dysfunction in ME/CFS. This review integrates current evidence on the potential role of HPA axis dysregulation and related neurobiological alterations in chronic stress-associated cognitive dysfunction in ME/CFS, with the aim of providing a theoretical basis for identifying potential intervention targets and informing strategies centered on HPA axis regulation.

Summary

Keywords

chronic stress, cognitive dysfunction, Hippocampus, hypothalamic-pituitary-adrenal, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Received

19 February 2026

Accepted

03 April 2026

Copyright

© 2026 Kang, Shao, Shi, Wang, Xiong, Jin and Ren. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jixiang Ren

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics